Is the weekend effect true in acute stroke patients at tertiary stroke center?

J Neurol Sci. 2021 Aug 15:427:117557. doi: 10.1016/j.jns.2021.117557. Epub 2021 Jun 24.

Abstract

Background: There is contradicting evidence on the outcome of emergency patients treated during weekends versus weekdays. We studied if outcome of ischemic stroke patients receiving intravenous thrombolysis (IVT) differs according to the treatment time.

Methods: Our retrospective study included consecutive patients receiving IVT within 4.5 h of stroke onset between June 1995 and December 2018 at the Helsinki University Hospital. The patients were compared based on the treatment initiation either during weekdays (Monday to Friday) or weekend (Saturday and Sunday). The primary outcome was 3-month mortality and secondary outcomes comprised 3-month modified Rankin Scale (mRS) and incidence of symptomatic intracerebral hemorrhage (sICH). Additional analyses studied the effect of IVT treatment according to non-office hours, time of day, and season.

Results: Of the 3980 IVT-treated patients, 28.0% received treatment during weekends. Mortality was similar after weekend (10.0%) and weekday (10.6%) admissions in the multivariable regression analysis (OR 0.78; 95% CI 0.59-1.03). Neither 3-month mRS (OR 0.98; 95% CI 0.86-1.12), nor the occurrence of sICH (4.2% vs 4.6%; OR 0.87; 95% CI 0.60-1.26) differed between the groups. No outcome difference was observed between the office vs non-office hours or by the time of day. However, odds for worse outcome were higher during autumn (OR 1.19; 95% CI 1.04-1.35) and winter (OR 1.15; 95% CI 1.01-1.30).

Conclusion: We did not discover any weekend effect for IVT-treated stroke patients. This confirms that with standardized procedures, an equal quality of care can be provided to patients requiring urgent treatment irrespective of time.

Keywords: Circadian rhythm; Functional outcome; Ischaemic stroke; Mortality; Thrombolysis; Weekend effect.

MeSH terms

  • Administration, Intravenous
  • Brain Ischemia* / complications
  • Brain Ischemia* / drug therapy
  • Brain Ischemia* / epidemiology
  • Cerebral Hemorrhage / drug therapy
  • Cerebral Hemorrhage / epidemiology
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Retrospective Studies
  • Stroke* / drug therapy
  • Stroke* / epidemiology
  • Thrombolytic Therapy
  • Time Factors
  • Treatment Outcome

Substances

  • Fibrinolytic Agents